Bharat Biotech to get Genome Valley Excellence Award
February 16, 2021
× BioAsia, a biotechnology and life sciences forum organised by the Telangana governement, has announced that the Genome Valley Excellence Award for 2021 will be given to Bharat Biotech International for its breakthrough, pioneering research, development and commercialisation of vaccines including Covaxin.
Krishna M Ella, Chairman and Managing Director, and Suchitra Ella, Joint Managing Director, Bharat Biotech International, will receive the award on February 22 during the inaugural event of BioAsia 2021.
Bharat Biotech was selected by the International Advisory Board of BioAsia comprising Ajit Shetty, Corporate Vice-President - Global Operations, Johnson & Johnson USA, (retd) and Chairman Emeritus, Janssen Pharmaceutica, Belgium; Makarand Jawadekar, former Director, Pfizer, USA; Robert Naismith, former Chairman, JUJAMA, US, among others, for its vision and commitment to developing the first indigenous va
BioAsia bestows Bharat Biotech with Genome Valley Excellence Award for 2021
BioAsia bestows Bharat Biotech with Genome Valley Excellence Award for 2021
17 February 2021 | News Bharat Biotech was selected by the International Advisory Board of BioAsia
BioAsia has announced that the prestigious Genome Valley Excellence Award for the year 2021 will be bestowed upon Bharat Biotech International Limited for its breakthrough, pioneering research, development and commercialisation of vaccines including COVAXIN™ (COVID-19 Vaccine), Rabies vaccine, Rotavirus vaccine, Japanese Encephalitis vaccine, Polio vaccine and Typhoid Conjugate vaccines, among others that have helped save billions of lives globally.
Dr Krishna M Ella, Chairman & Managing Director, and Suchitra Ella, Joint Managing Director, Bharat Biotech International will receive the award on February 22, 2021, during the inaugural event of BioAsia 2021.
In efforts to integrate GRB in Indias budgeting process, the Government of India introduced the Gender Budget Statement (GBS) in the Union Budget in 2005-06. It constitutes two parts- Part A reflects women-specific schemes having 100% allocation for women, and Part B reflects pro-women schemes, where at least 30% of the allocation is for women.
Harsh Vardhan termed the PM Aatmanirbhar Swasth Yojana a gift of self-reliant healthy India scheme.
New Delhi:
Union Health Minister Harsh Vardhan has appreciated the 2021-2022 Budget, saying the allocation of Rs 35,000 crore for COVID-19 vaccines and commitment to provide further support will help end this pandemic and expedite economic recovery.
He hailed the visionary leadership of Prime Minister Narendra Modi and prudence of Finance Minister Nirmala Sitharaman for taking us closer to Health For All . A remarkable 137 per cent increase, taking budgeted outlay for health and wellbeing to Rs 2,23,846 crore, he said.
The government has proposed a budget outlay of Rs 2,23,846 crore for health and well being in 2021-2022, an increase of 137 per cent from the previous year, with Rs 35,000 crore earmarked for COVID-19 vaccine in the upcoming fiscal.
Total allocation for health ministry up only 7%, no increase in budget for Ayushman Bharat
Allocation for health ministry stands at Rs 73,931.77 cr , up from Rs 69,000 cr last year. AYUSH ministry budget stands at Rs 2,970 cr, up from last year’s Rs 2,122 cr.
Abantika Ghosh 1 February, 2021 3:40 pm IST Text Size:
A+
New Delhi: Despite Finance Minister Nirmala Sitharaman’s stress on health and wellness being one of the six pillars of Atmanirbhar Bharat (self-reliant India), the actual increase in the allocation for the Ministry of Health and Family Welfare is a modest 7 per cent, according to the documents of Budget 2021.
The 137 per cent hike that the finance minister announced includes sundry other allocations such as for water supply, sanitation, and mitigation of air pollution etc bundled under a new head of “health and wellness”.